Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online August 11, 2005
Stem Cells Vol. 24 No. 1 January 2006, pp. 44 -54
doi:10.1634/stemcells.2005-0070; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0070v1
24/1/44    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cherqui, S.
Right arrow Articles by Salomon, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cherqui, S.
Right arrow Articles by Salomon, D. R.

TISSUE-SPECIFIC STEM CELLS

Isolation and Angiogenesis by Endothelial Progenitors in the Fetal Liver

Stephanie Cherquia, Sunil M. Kuriana, Olivier Schusslera, Johannes A. Hewelb, John R. Yates, IIIb, Daniel R. Salomona

a Department of Molecular and Experimental Medicine;
b Department of Cell Biology, The Scripps Research Institute, La Jolla, California, USA

Key Words. Endothelial progenitor cells • Angiogenesis • Murine fetal liver • CD31+Sca1+ cells

Correspondence: Daniel R. Salomon, M.D., Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. Telephone: 858-784-9381; Fax: 858-784-2121; e-mail: dsalomon{at}scripps.edu

Endothelial progenitor cells (EPCs) have significant therapeutic potential. However, the low quantity of such cells available from bone marrow and their limited capacity to proliferate in culture make their use difficult. Here, we present the first definitive demonstration of the presence of true EPCs in murine fetal liver capable of forming blood vessels in vivo connected to the host’s vasculature after transplantation. This population is particularly interesting because it can be obtained at high yield and has a high angiogenic capacity as compared with bone marrow–derived EPCs. The EPC capacity is contained within the CD31+Sca1+ cell subset. We demonstrate that these cells are dependent for survival and proliferation on a feeder cell monolayer derived from the fetal liver. In addition, we describe a novel and easy method for the isolation and ex vivo proliferation of these EPCs. Finally, we used gene expression profiling and tandem mass spectrometry proteomics to examine the fetal liver endothelial progenitors and the feeder cells to identify possible proangiogenic growth factor and endothelial differentiation-associated genes.




This article has been cited by other articles:


Home page
DevelopmentHome page
L. Pardanaud and A. Eichmann
Identification, emergence and mobilization of circulating endothelial cells or progenitors in the embryo
Development, July 1, 2006; 133(13): 2527 - 2537.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2006 by AlphaMed Press.